The use of intravenous iodinated contrast enhancement computed tomography (IV CECT) with has increased over recent decades. However, pre-existent kidney diseases in patients undergoing this procedure may increase the risk of developing comorbidities. This study intends to provide information on risk factors to predict kidney diseases in patients undergoing intravenous iodinated contrast-enhanced computed tomography (IV CECT). Contrast-induced nephropathy (CIN) is a major adverse effect of intravascular administration of iodinated contrast medium.
Pre-existent kidney disease is considered the most important risk for CIN. In this way, predicting kidney diseases before CECT can prevent the occurrence of CIN. In addition, CIN can be prevented if it is known early. Knowing CIN: In most studies, CIN is defined as an absolute (≥0.5 mg/dL) or relative (≥25 %) increase in serum creatinine within…
